In HCC patients, the number of CTCs was consistent with BCLC stage progression, with a significant increase in stage C compared to patients in stage A. CD90, CD133, and vimentin(+) CTC counts were significantly increased in patients with stage C compared to HCs (Fig. 2B). The gene discussed is THY1; the disease is hepatocellular carcinoma.